BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

24 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
47
Aminopyrazine diol compounds as PI3K-y inhibitorsBDB
Incyte
227
INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASEBDB
University ff Texas System
476
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosisBDB
Idorsia Pharmaceuticals
2
Selective ligands for tau aggregatesBDB
Sentonix
59
PYRAZOLOPYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOFBDB
Japan Tobacco
4
Inhibitors of SARM1 NADase activity and uses thereofBDB
Washington University
264
BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTSBDB
Otsuka Pharmaceutical
32
HETEROAROMATIC RING COMPOUND AS RET KINASE INHIBITOR, AND PREPARATION AND USE THEREOFBDB
Jiangsu Chia Tai Fenghai Pharmaceutical
56
ALK-5 inhibitors and uses thereofBDB
Sumitomo Pharma Oncology
93
Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitorsBDB
Hoffmann-La Roche
5
PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseasesBDB
H. Lundbeck
29
Tricyclic compounds useful to treat orthomyxovirus infectionsBDB
Novartis
152
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofBDB
Enanta Pharmaceuticals
9
AMPK activatorsBDB
Kallyope
39
Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereofBDB
Shanghai Institute of Material Medica, Chinese Academy of Sciences
26
Diarylalkanes as potent inhibitors of binuclear enzymesBDB
Unigen
130
Melanocortin receptor-specific peptidesBDB
Palatin Technologies
101
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1BDB
Novartis
141
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2BBDB
Cadent Therapeutics
52
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5BDB
Vanderbilt University
39
Substituted aminopyrimidine compounds and methods of useBDB
Calitor Sciences
24
6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligandsBDB
Rottapharm
81
PHENYL AMIDE COMPOUNDS AND METHODS OF USEBDB
Schrodinger